Digest Network Come funziona
Network
/
Società
Av
Non verificato

Avenacy

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaSaluteSanità

26 comunicati stampa

Guarda tutti i comunicati
17/06/2026
Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
11/05/2026
Avenacy Announces Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
16/03/2026
Eventi
Biotecnologia
Farmaceutica
Salute
Avenacy to Attend 2026 DCAT Week
Fonte
Avenacy
Emittente
Business Wire
1.00
0
02/03/2026
Avenacy Announces Launch of Diphenhydramine Hydrochloride Injection, USP in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
08/01/2026
Eventi
Biotecnologia
Sanità
Farmaceutica
Salute
Avenacy Provides Update on Business Progress and Announces 2026 Strategic Priorities Ahead of 44th Annual J.P. Morgan Healthcare Conference
Fonte
Avenacy
Emittente
Business Wire
1.00
0
17/12/2025
Eventi
Biotecnologia
Farmaceutica
Salute
Avenacy to Attend J.P. Morgan 44th Annual Healthcare Conference
Fonte
Avenacy
Emittente
Business Wire
1.00
0
03/12/2025
Farmaceutica
Salute
Sanità
Attrezzature medico-sanitarie
Eventi
Industria
Avenacy to Attend 2025 ASHP Midyear Clinical Meeting and Exhibition
Fonte
Avenacy
Emittente
Business Wire
1.00
0
22/10/2025
Eventi
Fiere
Salute
Farmaceutica
Avenacy to Highlight 2025 Achievements and Partnership Opportunities at CPHI Frankfurt
Fonte
Avenacy
Emittente
Business Wire
1.00
0
25/08/2025
Biotecnologia
Igiene alimentare
Salute
Industria
Vetrine/Shopping
Farmaceutica
Medicina - Varie
Infanzia
Sanità
Odontoiatria
Avenacy Announces Launch of Lidocaine Hydrochloride Injection, USP in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
21/07/2025
Avenacy Announces Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0